Drug Metabolism Functionalization (Phase I) Reactions | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata | |
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata | |
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata | |
| dc.conicet.organizacion | Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos | |
| dc.conicet.paginas | 1500 | es |
| dc.contributor.author | Talevi, Alan | |
| dc.contributor.author | Bellera, Carolina Leticia | |
| dc.contributor.other | Talevi, Alan | |
| dc.date.issued | 2021 | es |
| dc.description.abstract | Functionalization (or Phase I) reactions of drug metabolism are those that introduce a functional drug to their substrates (for instance, in hydroxylation) or modify an existing one (e.g., in hydrolysis). The term functionalization is sometimes preferred to Williams’ classic Phase I denomination. Williams’ nomenclature reflects the usual scheme of sequential metabolism, where the parent drug is converted to a primary, or first-generation, metabolite, which in turn is subjected to a second biotransformation reaction that yields a secondary, or second-generation, metabolite. Whereas it is true that functionalization reactions often “prepare” their substrate to undergo a conjugation (Phase II) reaction (because they provide the substrate with a chemical “anchor” site for a conjugation to occur, such as a -OH or a -NH function), there are many deviations from this too general scheme. For instance, many Phase I metabolites are excreted without experiencing Phase II reactions. Similarly, the intact drug may directly undergo a Phase II transformation without a previous Phase I reaction. A drug may undergo one or more subsequent Phase I reactions before being conjugated (see Fig. 1 for figures). Finally, drug metabolism tends to operate in parallel and not only serially, since many different biotransformations occur simultaneously to different drug molecules of the same compound. | es |
| dc.description.fil | Fil: Talevi, Alan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina | |
| dc.description.fil | Fil: Bellera, Carolina Leticia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Talevi, Alan; Bellera, Carolina Leticia; Drug Metabolism Functionalization (Phase I) Reactions; Springer Nature Switzerland AG; 2021; 1-7 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.isbn | 978-3-030-51519-5 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/156392 | |
| dc.journal.ciudad | Basignstoke | es |
| dc.journal.pagination | 1-7 | es |
| dc.journal.pais | Reino Unido | es |
| dc.language.iso | eng | es |
| dc.publisher | Springer Nature Switzerland AG | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/referenceworkentry/10.1007/978-3-030-51519-5_63-1 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/978-3-030-51519-5_63-1 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.source.titulo | The ADME Encyclopedia | es |
| dc.subject | DRUG METABOLISM | es |
| dc.subject | CLEARENCE | es |
| dc.subject | CYP450 | es |
| dc.subject | CYPS | es |
| dc.subject.classification | Otras Ciencias Biológicas | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Drug Metabolism Functionalization (Phase I) Reactions | es |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | info:eu-repo/semantics/bookPart | |
| dc.type | info:ar-repo/semantics/parte de libro | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.bc9f4880-9b69-44d5-b08a-d5dc193a588d_A.pdf
- Tamaño:
- 331.29 KB
- Formato:
- Adobe Portable Document Format